Mike Matson
Stock Analyst at Needham
(2.39)
# 2,339
Out of 4,829 analysts
519
Total ratings
41.73%
Success rate
-1.81%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Maintains: Buy | $64 → $57 | $33.05 | +72.47% | 15 | May 9, 2025 | |
| HAE Haemonetics | Maintains: Buy | $104 → $84 | $68.19 | +23.19% | 13 | May 8, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Buy | $42 | $22.04 | +90.56% | 23 | May 8, 2025 | |
| VCYT Veracyte | Maintains: Buy | $51 → $41 | $29.71 | +38.00% | 17 | May 8, 2025 | |
| AORT Artivion | Reiterates: Buy | $32 | $28.91 | +10.69% | 17 | May 6, 2025 | |
| HOLX Hologic | Reiterates: Hold | n/a | $56.75 | - | 20 | May 2, 2025 | |
| CNMD CONMED | Maintains: Buy | $91 → $61 | $57.08 | +6.87% | 24 | May 1, 2025 | |
| SRDX Surmodics | Reiterates: Hold | n/a | $26.91 | - | 21 | Apr 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $51 → $44 | $31.00 | +41.94% | 34 | Apr 30, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $18 → $8.5 | $8.05 | +5.59% | 25 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.45 | - | 19 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $116 → $100 | $95.83 | +4.35% | 26 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $115 | $102.86 | +11.80% | 29 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $111.50 | - | 9 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | n/a | $33.92 | - | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.13 | +165.49% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $156.57 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.04 | +38.89% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.23 | - | 18 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4.25 | $2.87 | +48.08% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $138.13 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $226.43 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $442 | $380.92 | +16.03% | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $44.06 | +45.26% | 25 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $125.11 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $297.32 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $83.48 | - | 17 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $95.21 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $245.04 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $18.49 | +127.15% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $55.82 | +34.36% | 1 | Feb 18, 2021 |
Enovis
May 9, 2025
Maintains: Buy
Price Target: $64 → $57
Current: $33.05
Upside: +72.47%
Haemonetics
May 8, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $68.19
Upside: +23.19%
OrthoPediatrics
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $22.04
Upside: +90.56%
Veracyte
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $29.71
Upside: +38.00%
Artivion
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $28.91
Upside: +10.69%
Hologic
May 2, 2025
Reiterates: Hold
Price Target: n/a
Current: $56.75
Upside: -
CONMED
May 1, 2025
Maintains: Buy
Price Target: $91 → $61
Current: $57.08
Upside: +6.87%
Surmodics
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $26.91
Upside: -
AtriCure
Apr 30, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $31.00
Upside: +41.94%
NeoGenomics
Apr 29, 2025
Maintains: Buy
Price Target: $18 → $8.5
Current: $8.05
Upside: +5.59%
Apr 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.45
Upside: -
Apr 25, 2025
Maintains: Buy
Price Target: $116 → $100
Current: $95.83
Upside: +4.35%
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $115
Current: $102.86
Upside: +11.80%
Apr 23, 2025
Reiterates: Hold
Price Target: n/a
Current: $111.50
Upside: -
Apr 14, 2025
Initiates: Hold
Price Target: n/a
Current: $33.92
Upside: -
Apr 11, 2025
Reiterates: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $156.57
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $5.04
Upside: +38.89%
Apr 9, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.23
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $4.25
Current: $2.87
Upside: +48.08%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $138.13
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $226.43
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $442
Current: $380.92
Upside: +16.03%
Mar 17, 2025
Reiterates: Buy
Price Target: $64
Current: $44.06
Upside: +45.26%
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $125.11
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $297.32
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $83.48
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $95.21
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $245.04
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $18.49
Upside: +127.15%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $55.82
Upside: +34.36%